SummaryMetallothionein (MT) is a protein which contains 20 cysteine residues but no aromatic amino acids. It was tested whether treatment of male rats with the hepatocarcinogen diethylnitrosamine (DENA) could ethylate nucleic acids in such a way that protein variants containing measurable amounts of aromatic amino acid residues could be isolated from the livers of treated animals. To give a low Iimit of detection, the "wrong" amino acid precursors were administered in radiolabelled form at high Ievels of activity (7 mCijkg each of [ 3 H]tyrosine and [ 3 H]phenylalanine). 11 p.Cijkg [ 14 C]cysteine was given as an intemal marker for MT biosynthesis. 6 h after amino acid administration, metallothionein (MT) was isolated from the liver and extensively purified. Afteracid hydrolysis and collection of Cys, Tyr, and Phe from an HPLC analysis of the amino acids, the 3 Hj 14 C ratio was determined. The carcinogen-treated rats exhibited a significantly higher ratio than the vehicle-treated animals. This type of in vivo assay might find interesting applications in the investigation of nucleic acid alkylations as promutagenic lesions.Since a !arge number of chemical carcinogens act by damaging DNA, many short-term screening tests for carcinogenicity are based upon the detection of mutational events. In the light of the recent findings that certain cellular proto-oncogenes can be activated by base Substitutions (refs. in Weinberg, 1985) the search for changes in amino acid composition of proteins could become a valuable tool.One majorproblern in proteinvariant analysis in non-clonal systems is the fact that minor changes in the relative abundance of the various amino acids in a small number of polypeptide * Present address: